Achieve Life Sciences, Inc. (FRA:SP4P)
Germany · Delayed Price · Currency is EUR 4.090
0.00 (0.00%)
At close: Nov 28, 2025
Achieve Life Sciences Company Description
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms.
It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Achieve Life Sciences, Inc.
| Country | United States |
| Industry | Pharmaceutical Preparations |
| Employees | 25 |
| CEO | Richard A. Stewart |
Contact Details
Address: 22722 29th Dr. SE Bothell, Delaware 98021 United States | |
| Phone | 604 210 2217 |
| Website | achievelifesciences.com |
Stock Details
| Ticker Symbol | SP4P |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Richard A. Stewart | Chief Executive Officer |
| Mark Oki | Chief Financial Officer |
| Craig Donnelly | Chief Operating Officer |